- Researchers demonstrate the double advantage of killer T-cells used in cancer immunotherapy News-Medical.Net
- Hua Highlights Innovative Research With Immunotherapy in NETs OncLive
- 'Masked' cancer drug stealthily trains immune system to kill tumors while sparing healthy tissues Japan Today
- Synthetic IL-9 receptor allows T cells to fight cancer without the need for chemo or radiation News-Medical.Net
- Researchers use nanotechnology to destroy and prevent relapse of solid tumor cancers Phys.org
- View Full coverage on Google News
Researchers demonstrate the double advantage of killer T-cells used in cancer immunotherapy – News-Medical.Net
ByGoogle News
May 26, 2022